Thursday, January 3, 2019

Thousand Oaks Biopharmaceuticals Gets $45M In Series A For Biotech Manufacturing

Thousand Oaks- and Shanghai-based Thousand Oaks Biopharmaceuticals, a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round. The funding came from New Alliance Capital, plus ADDOR Capital, Tenyall & Sumin, Broadhi Capital, QianRong, Ji Lin Ao Dong, and Bluebay Capital. According to

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.